121 related articles for article (PubMed ID: 15062567)
1. Effect of erythropoietin on Leydig cell is associated with the activation of Stat5 pathway.
Yamazaki T; Kanzaki M; Kamidono S; Fujisawa M
Mol Cell Endocrinol; 2004 Jan; 213(2):193-8. PubMed ID: 15062567
[TBL] [Abstract][Full Text] [Related]
2. Association of CrkL with STAT5 in hematopoietic cells stimulated by granulocyte-macrophage colony-stimulating factor or erythropoietin.
Ota J; Kimura F; Sato K; Wakimoto N; Nakamura Y; Nagata N; Suzu S; Yamada M; Shimamura S; Motoyoshi K
Biochem Biophys Res Commun; 1998 Nov; 252(3):779-86. PubMed ID: 9837784
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
[TBL] [Abstract][Full Text] [Related]
4. Lactogenic hormone-inducible phosphorylation and gamma-activated site-binding activities of Stat5b in primary rat Leydig cells and MA-10 mouse Leydig tumor cells.
Kanzaki M; Morris PL
Endocrinology; 1998 Apr; 139(4):1872-82. PubMed ID: 9528973
[TBL] [Abstract][Full Text] [Related]
5. Duration of STAT5 activation influences the response of interleukin-2 receptor alpha gene to different cytokines.
Imbert V; Renauld PR
Eur Cytokine Netw; 1999 Mar; 10(1):71-8. PubMed ID: 10210776
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
Feldman L; Wang Y; Rhim JS; Bhattacharya N; Loda M; Sytkowski AJ
Prostate; 2006 Feb; 66(2):135-45. PubMed ID: 16161153
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma.
Lai SY; Childs EE; Xi S; Coppelli FM; Gooding WE; Wells A; Ferris RL; Grandis JR
Oncogene; 2005 Jun; 24(27):4442-9. PubMed ID: 15856028
[TBL] [Abstract][Full Text] [Related]
8. Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells.
Ammarguellat F; Llovera M; Kelly PA; Goffin V
Biochem Biophys Res Commun; 2001 Jun; 284(4):1031-8. PubMed ID: 11409898
[TBL] [Abstract][Full Text] [Related]
9. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
10. Expression of erythropoietin in human female reproductive organs.
Yasuda Y; Fujita Y; Musha T; Tanaka H; Shiokawa S; Nakamatsu K; Mori S; Matsuo T; Nakamura Y
Ital J Anat Embryol; 2001; 106(2 Suppl 2):215-22. PubMed ID: 11732580
[TBL] [Abstract][Full Text] [Related]
11. Prolactin signals through RUSH/SMARCA3 in the absence of a physical association with Stat5a.
Hewetson A; Moore SL; Chilton BS
Biol Reprod; 2004 Dec; 71(6):1907-12. PubMed ID: 15306550
[TBL] [Abstract][Full Text] [Related]
12. Differential function of STAT5 isoforms in head and neck cancer growth control.
Leong PL; Xi S; Drenning SD; Dyer KF; Wentzel AL; Lerner EC; Smithgall TE; Grandis JR
Oncogene; 2002 Apr; 21(18):2846-53. PubMed ID: 11973644
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone increases Stat5 and Stat1 expression in lactating goat mammary gland: a specific effect compared to milking frequency.
Boutinaud M; Jammes H
Domest Anim Endocrinol; 2004 Nov; 27(4):363-78. PubMed ID: 15519040
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans.
Brelje TC; Svensson AM; Stout LE; Bhagroo NV; Sorenson RL
J Histochem Cytochem; 2002 Mar; 50(3):365-83. PubMed ID: 11850439
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
[TBL] [Abstract][Full Text] [Related]
16. Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation.
Hamadmad SN; Hohl RJ
Biochem Pharmacol; 2007 Aug; 74(4):590-600. PubMed ID: 17586475
[TBL] [Abstract][Full Text] [Related]
17. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.
Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H
Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271
[TBL] [Abstract][Full Text] [Related]
18. STAT1 is involved in signal transduction in the EPO induced HEL cells.
Chu J; Gui CY; Fan J; Tang XD; Qiao RL
Cell Res; 1998 Jun; 8(2):105-17. PubMed ID: 9669026
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activation of Stat5b contributes to carcinogenesis in vivo.
Xi S; Zhang Q; Gooding WE; Smithgall TE; Grandis JR
Cancer Res; 2003 Oct; 63(20):6763-71. PubMed ID: 14583472
[TBL] [Abstract][Full Text] [Related]
20. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation.
Livnah O; Johnson DL; Stura EA; Farrell FX; Barbone FP; You Y; Liu KD; Goldsmith MA; He W; Krause CD; Pestka S; Jolliffe LK; Wilson IA
Nat Struct Biol; 1998 Nov; 5(11):993-1004. PubMed ID: 9808045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
